Top Rated Posters
ECCMID 2023 top-rated abstracts and posters
Top-rated abstracts include abstracts selected for the oral sessions with a review score greater of equal to 5.5 (out of max grade 6.0)
Top-rated posters include posters selected for poster presentation in each category from 0.1-0.3% top-rated abstracts with a score grated or equal to 5.0 (out of max grade 6.0)
Top-rated abstracts
| Type session | Abstract | Abstract title | Co-Authors List | |
|---|---|---|---|---|
Presentations 15.04 | ||||
| 1-H Case Session | 6506 | A case of septic arthritis and hyperammonemia syndrome caused by disseminated Ureaplasma urealyticum following B-cell maturation CD3-directed bispecific antibody | Anthony LIEU (1, 2), Chu Qi WANG (3), Peter Raymond DUGGAN (4), Stephen Douglas VAUGHAN (2) - (1)Division of Infectious Diseases and Medical Microbiology, Department of Medicine, McGill University, Canada, (2)Division of Infectious Diseases, Department of Medicine, University of Calgary, Canada, (3)Department of Medicine, University of Ottawa, Canada, (4)Division of Hematology, Department of Medicine, University of Calgary, Canada | |
| 2-H Oral Session | 3200 | The spatial distribution of transcriptomics lung immune responses during chronic lung infection by opportunistic pathogens | Federico DI MARCO (1), Francesca NICOLA (1), Fabio SALIU (1), Stefano DE PRETIS (2), Caterina ONETO (2), Francesca GIANNESE (2), Daniela Maria CIRILLO (1), Nicola Ivan LORÈ (1) - (1)Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Italie, (2)Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Italie | |
| 1-H Oral Session | 2508 | Intra articular injection(s) of active bacteriophages as adjuvant therapy in patients with prosthetic joint infections (PJI) qualified for open or arthroscopic “Debridement Antibiotics & Implant Retention” (DAIR) followed by suppressive antimicrobial therapy (SAT): the PHAGEinLYON experience at the CRIOAc Lyon referral centre | Tristan FERRY (1, 2, 3), Thomas BRIOT (1), Camille KOLENDA (1, 2, 3), Clément JAVAUX (1, 3), Gilles LEBOUCHER (1), Fabien CRAIGHERO (1, 3), Sébastien LUSTIG (1, 3), Frederic LAURENT (1, 2, 3), Cecile BATAILLER (1, 3) - (1)Hôpital de la Croix-Rousse, HCL, France, (2)Centre International de Recherche en Infectiologie , France, (3)Centre Interrégional de Référence Pour la Prise en Charge des Infections Ostéo-Articulaires Complexes (CRIOAc Lyon), Hospices Civils de Lyon, France | |
| 1-H ePoster Flash Session | 1072 | Tixagevimab/cilgavimab pre-exposure prophylaxis in lung transplant recipients during the Omicron wave: a real-world monocentric experience | Andrea CONA (1), Alessandro TAVELLI (2), Stefano AGRENZANO (1), Giovanni SCIANNA (3), Angelo MARIA (3), Francesco MARINO (4), Elizabeth DE LA CRUZ (5), Maria DI GIORGIO (5), Eglys OSORIO (5), Angelo LUCA (6), Alessio PROVENZANI (7), Patrizio VITULO (8), Alessandro BERTANI (8), Alessandra MULARONI (1) - (1)Department of Infectious Diseases, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Italie, (2)Unit of Infectious Diseases, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Italie, (3)Transplant coordinator Nurses, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Italie, (4)Clinical coordination of Nursing Services, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Italie, (5)Nursing Services, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Italie, (6)Department of Diagnostic and Therapeutic Services, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Italie, (7)Clinical Pharmacy, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Italie, (8)Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Italie | |
Presentations 16.04 | ||||
| 2-H Oral Session | 4326 | Fine-scale spatial and longitudinal survey of AMR prevalence, antibiotic prescribing and antibiotic residues across Oxfordshire wastewater treatment works (WWTWs) | Kevin CHAU (1, 2), Natalie SIMS (3), Karen EASTERBROOK (4), Richard WHINTON (4), Karina-Doris VIHTA (1, 2, 5), Emma PRITCHARD (1), Howard BRETT (4), Jennifer HUGHES (4), Robert PRITCHARD (4), Barbara KASPRZYK-HORDERN (3), Soon GWEON (6), Derrick CROOK (1, 2, 7), Daniel READ (8), Sarah WALKER (1, 2, 7), Nicole STOESSER (1, 2, 7) - (1)Nuffield Department of Medicine, John Radcliffe Hospital, Royaume-Uni, (2)NIHR Health Protection Research Unit in Antimicrobial Resistance and Healthcare-associated Infection, Royaume-Uni, (3)Department of Chemistry, University of Bath, Royaume-Uni, (4)Thames Water, Royaume-Uni, (5)Department of Engineering, Royaume-Uni, (6)University of Reading, Royaume-Uni, (7)NIHR Oxford Biomedical Research Centre, Royaume-Uni, (8)UK Centre for Ecology & Hydrology, Royaume-Uni | |
| 1-H Oral Session | 1800 | Pseudomonas aeruginosa UDP-glucose pyrophosphorylase: an antivirulence drug target | Sven CLEEVES (1), Larissa DIRR (2), Isabel RAMÓN ROTH (3), Linghui LI (2), Mark VON ITZSTEIN (2), Susanne HÄUßLER (4, 5, 6), Rita GERARDY-SCHAHN (3), Armin BRAUN (1), Jana FÜHRING (3) - (1)Fraunhofer Institute for Toxicology and Experimental Medicine, Allemagne, (2)Institute for Glycomics, Griffith University, Gold Coast Campus, Australie, (3)Institute of Clinical Biochemistry, Hannover Medical School, Allemagne, (4)Department of Molecular Bacteriology, Helmholtz Centre for Infection Research, Allemagne, (5)Institute for Molecular Bacteriology, TWINCORE, Centre for Experimental and Clinical Infection Research, Allemagne, (6)Department of Clinical Microbiology, Copenhagen University Hospital-Rigshospitalet, Danemark | |
| 2-H Oral Session | 5512 | Global phylogeography and genomic surveillance of carbapenem-resistant ST15 blaOXA-232-carrying Klebsiella pneumoniae | Yuye WU, Zhi RUAN - (1)Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Chine | |
| 2-H Oral Session | 562 | Interim safety and immunogenicity results of a bivalent SARS-CoV-2 Omicron booster vaccine: a phase 3, randomised, observer-blind, active-controlled trial | Ivan T. LEE (1), Catherine A. COSGROVE (2), Patrick MOORE (3, 4), Marcin BULA (5), Philip KALRA (6), Paul DARGAN (7), Rebecca CLARK (8), Marta BOFFITO (9, 10), Ray SHERIDAN (11), Claire BETHUNE (12), Fiona BURNS (13), Dinesh SARALAYA (14, 15), Rhiannon NALLY (16), Christopher J. A. DUNCAN (17, 18), David CHADWICK (19), Adrian PALFREEMAN (20), Alberto San Francisco RAMOS (2), Paul T. HEATH (2), Bethany GIRARD (1), Christy PARKER (1), Dondi RUST (1), Shraddha MEHTA (1), Elizabeth DE WINDT (1), Andrea SUTHERLAND (1), Laree TRACY (1), Honghong ZHOU (1), Jacqueline MILLER (1), Rituparna DAS (1) - (1)Moderna, Inc., États-Unis, (2)Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, Royaume-Uni, (3)The Adam Practice, Royaume-Uni, (4)University Hospital Southampton NHS Foundation Trust, Royaume-Uni, (5)University of Liverpool, Royaume-Uni, (6)Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Royaume-Uni, (7)Guy’s & St Thomas’ NHS Foundation Trust, King’s College London, Royaume-Uni, (8)Layton Medical Centre, Royaume-Uni, (9)Chelsea and Westminster Hospital NHS Foundation Trust, Royaume-Uni, (10)Imperial College London, Royaume-Uni, (11)Royal Devon University Hospital, Royaume-Uni, (12)University Hospitals Plymouth NHS Trust, Royaume-Uni, (13)University College London, Royaume-Uni, (14)National Institute for Health Research Patient Recruitment Centre, Royaume-Uni, (15)Bradford Teaching Hospitals NHS Foundation Trust, Royaume-Uni, (16)Wansford and Kings Cliffe Practice, Royaume-Uni, (17)Translational and Clinical Research Institute, Newcastle University, Royaume-Uni, (18)NIHR Newcastle Clinical Research Facility, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Royaume-Uni, (19)South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Royaume-Uni, (20)University Hospitals of Leicester NHS Trust, Royaume-Uni | |
Presentations 17.04 | ||||
| 1-H ePoster Flash Session | 2857 | Diphtheria outbreak among young asylum seekers in a national asylum centre in Basel, Switzerland | Branislav IVAN (1), Pascal SCHLAEPFER (2), Rahel WAMPFLER (1, 3), Claudia LANG (1), Melanie KRAUS (4), Ulrich HEININGER (5), Pascal URWYLER (6), Sarah TSCHUDIN-SUTTER (6), Daniel GOLDENBERGER (1) - (1)Division of Clinical Microbiology, University Hospital Basel, Suisse, (2)Laboratory Medicine, University Hospital Basel, Suisse, (3)MCL Medical Laboratories, Suisse, (4)Cantonal Medical Service, Department of Health, Canton of Basel-Stadt, Suisse, (5)Paediatric Infectiology and Vaccinology, University Children's Hospital Basel, Suisse, (6)Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Suisse | |
| 1-H ePoster Flash Session | 3532 | Collateral damage: rifaximin use and the emergence of daptomycin-resistant Enterococcus faecium | Adrianna TURNER (1), Lucy LI (1), Ian MONK (1), Jean LEE (1, 2), Danielle INGLE (1), Sebastian DUCHENE (1), Nichollas SCOTT (1), Tim STINEAR (1), Jason KWONG (1, 3), Claire GORRIE (1, 4), Benjamin HOWDEN (1, 4), Glen CARTER (1) - (1)University of Melbourne, Australie, (2)Monash Health, Australie, (3)Austin Health, Australie, (4)Microbiological Diagnostic Unit Public Health Laboratory, Australie | |
| 1-H Oral Session | 592 | Interim safety and immunogenicity results of a bivalent SARS-CoV-2 Omicron booster vaccine: a phase 3, randomised, observer-blind, active-controlled trial | Ivan T. LEE (1), Catherine A. COSGROVE (2), Patrick MOORE (3, 4), Marcin BULA (5), Philip KALRA (6), Paul DARGAN (7), Rebecca CLARK (8), Marta BOFFITO (9, 10), Ray SHERIDAN (11), Claire BETHUNE (12), Fiona BURNS (13), Dinesh SARALAYA (14, 15), Rhiannon NALLY (16), Christopher J. A. DUNCAN (17, 18), David CHADWICK (19), Adrian PALFREEMAN (20), Alberto San Francisco RAMOS (2), Paul T. HEATH (2), Bethany GIRARD (1), Christy PARKER (1), Dondi RUST (1), Shraddha MEHTA (1), Elizabeth DE WINDT (1), Andrea SUTHERLAND (1), Laree TRACY (1), Honghong ZHOU (1), Jacqueline MILLER (1), Rituparna DAS (1) - (1)Moderna, Inc., États-Unis, (2)Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, Royaume-Uni, (3)The Adam Practice, Royaume-Uni, (4)University Hospital Southampton NHS Foundation Trust, Royaume-Uni, (5)University of Liverpool, Royaume-Uni, (6)Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Royaume-Uni, (7)Guy’s & St Thomas’ NHS Foundation Trust, King’s College London, Royaume-Uni, (8)Layton Medical Centre, Royaume-Uni, (9)Chelsea and Westminster Hospital NHS Foundation Trust, Royaume-Uni, (10)Imperial College London, Royaume-Uni, (11)Royal Devon University Hospital, Royaume-Uni, (12)University Hospitals Plymouth NHS Trust, Royaume-Uni, (13)University College London, Royaume-Uni, (14)National Institute for Health Research Patient Recruitment Centre, Royaume-Uni, (15)Bradford Teaching Hospitals NHS Foundation Trust, Royaume-Uni, (16)Wansford and Kings Cliffe Practice, Royaume-Uni, (17)Translational and Clinical Research Institute, Newcastle University, Royaume-Uni, (18)NIHR Newcastle Clinical Research Facility, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Royaume-Uni, (19)South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Royaume-Uni, (20)University Hospitals of Leicester NHS Trust, Royaume-Uni | |
| 1-H Oral Session | 3251 | Pulmonary transcriptomics reveal immune dysfunction and exhaustion in mice with invasive pulmonary mucormycosis, partially restored by PD-L1 immune checkpoint blockade | Sebastian WURSTER, Nathaniel D. ALBERT, Stephanie S. WATOWICH, Dimitrios P. KONTOYIANNIS - (1)The University of Texas MD Anderson Cancer Center, États-Unis | |
| 1-H Oral Session | 4059 | Antibody-drug conjugate therapy of S. aureus implant-associated osteomyelitis in a murine model | Mikkel Illeman JOHANSEN (1, 2), Anne TVILUM (3), Lærke Nøhr GLUD (4), Diana Fischer MALSKÆR (4), Amanda Batoul KHAMAS (4), Snehit Satish MHATRE (4), Ane Bretschneider SØGAARD (3, 4), Emma FADDY (1, 2), Lars ØSTERGAARD (1), Rikke Louise MEYER (4, 5), Alexander N. ZELIKIN (3, 4), Nis Pedersen JØRGENSEN (1) - (1)Department of Infectious Diseases, Aarhus University Hospital, Danemark, (2)Department of Clinical Medicine, Aarhus University, Danemark, (3)Department of Chemistry, Aarhus University, Danemark, (4)Interdisciplinary Nanoscience Centre (iNANO), Aarhus University, Danemark, (5)Department of Biology, Aarhus University, Danemark | |
| 1-H ePoster Flash Session | 2971 | Severe infections as risk factors for acute myocardial infarction: a nationwide, population-based cohort study | Emilie M. J. PEDERSEN (1), Birgitte Lindegaard MADSEN (1), Gertrud Baunbæk EGELUND (1), Nicolai LOHSE (2), Christian TORP-PEDERSEN (3), Andreas Vestergaard JENSEN (1) - (1)Department of Pulmonary and Infectious Diseases, North Zealand Hospital, Danemark, (2)Department of Neuroanaesthesiology, Rigshospitalet, Danemark, (3)Department of Cardiology and Clinical Research, North Zealand Hospital, Danemark | |
Presentations 18.04 | ||||
| 2-H Oral Session | 4724 | Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments | Akshita GUPTA (1, 2), Angelina KONNOVA (1, 2), Mathias SMET (1, 2), Matilda BERKELL (1, 2), Alessia SAVOLDI (3), Matteo MORRA (3), Vincent VAN AVERBEKE (1), Fien DE WINTER (1), Denise PESERICO (4), Elisa DANESE (4), An HOTTERBEEKX (1), Elda RIGHI (3), Pasquale DE NARDO (3), Evelina TACCONELLI (3), Surbhi MALHOTRA-KUMAR (2), Samir KUMAR-SINGH (1, 2) - (1)Molecular Pathology Group, Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Belgique, (2)Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Belgique, (3)Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Italie, (4)Section of Clinical Biochemistry, University of Verona, Italie | |
| 1-H Case Session | 6545 | An eosinophillic end to a stag-party in Thailand | Charlotte PATTERSON (1), Rachel WAKE (2), Gauri GODBOLE (1, 3), Laura NABARRO (1) - (1)Hospital of Tropical Diseases, University College London Hospital NHS Foundation Trust, Royaume-Uni, (2)Institute of Infection and Immunity, St George's University of London, Royaume-Uni, (3)United Kingdom Health and Security Agency (UKHSA), Royaume-Uni | |
| 1-H Case Session | 6564 | Never get between an iguana and his cake: a cautionary tale of a subcutaneous mass following an iguana bite | Jordan MAH, Kyle WALDING, Brooke LIANG, Lawrence RINSKY, Roshni MATHEW, Niaz BANAEI - (1)Stanford University, États-Unis | |
| 2-H Oral Session | 483 | Genetic determinants of plasmid persistence in a comprehensive five-year, multi-centred population analysis of 1,071 closed carbapenemase-producing Enterobacterales genomes | Vanessa KOH (1, 2), Kalisvar MARIMUTHU (3, 4, 5), Indumathi VENKATACHALAM (6), Ze Qin LIM (1, 2), Sai Rama Sridatta PRAKKI (1, 2), Natascha May THEVASAGAYAM (1, 2), Benjamin CHERNG (6, 7, 5), Raymond FONG (8), Surinder KAUR PADA (9), Say Tat OOI (10), Nares SMITASIN (11, 5), Koh Cheng THOON (12), Li Yang HSU (13, 5, 14), Tse Hsien KOH (15, 7), Partha PRATIM DE (16), Thean Yen TAN (17), Douglas CHAN (18), Rama Narayana DEEPAK (19), Nancy TEE (20), Michelle ANG (21), Raymond LIN (21), Jeanette TEO (20), Oon Tek NG (3, 4, 22) - (1)Infectious Disease Research Laboratory, National Centre for Infectious Diseases, Singapour, (2)Tan Tock Seng Hospital, Singapour, (3)National Centre for Infectious Diseases, Singapour, (4)Department of Infectious Diseases, Tan Tock Seng Hospital, Singapour, (5)Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapour, (6)Department of Infectious Diseases, Singapore General Hospital, Singapour, (7)DUKE-NUS Graduate Medical School, National University of Singapore, Singapour, (8)Department of Infectious Diseases, Changi General Hospital, Singapour, (9)Department of Infectious Diseases, Ng Teng Fong General Hospital, Singapour, (10)Division of Infectious Diseases, Khoo Teck Puat Hospital, Singapour, (11)Division of Infectious Diseases, National University Hospital and National University Health System, Singapour, (12)Infectious Diseases Service, KK Women's and Children's Hospital, Singapour, (13)Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapour, (14)Singapore Centre for Environmental Life Sciences Engineering, National University of Singapore, Singapour, (15)Department of Microbiology, Singapore General Hospital, Singapour, (16)Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapour, (17)Department of Laboratory Medicine, Changi General Hospital, Singapour, (18)Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapour, (19)Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapour, (20)Department of Laboratory Medicine, National University Hospital and National University Health System, Singapour, (21)National Public Health Laboratory, National Centre for Infectious Diseases, Singapour, (22)Lee Kong Chian School of Medicine, Nanyang Technological University, Singapour | |
| 2-H Oral Session | 6354 | Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): findings from the United Kingdom randomised, controlled open-label, platform adaptive trial | Chris BUTLER (1), Richard HOBBS (1), Oghenekome GBINIGIE (1), Najib RAHMAN (1), Gail HAYWARD (1), Duncan RICHARDS (1), Jienchi DORWARD (1), David LOWE (2), Joseph STANDING (3), Judith BREUER (3), Saye KHOO (4), Stavros PETROU (1), Kerenza HOOD (5), Jonathan NGUYEN-VAN-TAM (6), Mahendra PATEL (1), Benjamin SAVILLE (7), Joe MARION (7), Emma OGBURN (1), Julie ALLEN (1), Heather RUTTER (1), Nick FRANCIS (8), Nicholas THOMAS (9), Philip EVANS (10), Melissa DOBSON (1), Tracie-Ann MADDEN (5), Jane HOLMES (1), Victoria HARRIS (1), May PNG (1), Mark LOWN (8), Oliver VAN HECKE (1), Michelle DETRY (7), Christina SAUNDERS (7), Mark FITZGERALD (7), Nicholas BERRY (7), Lazaro MWANDIGHA (1), Ushma GALAL (1), Sam MORT (1), Bhautesh JANI (11), Nigel HART (12), Haroon AHMED (5), Daniel BUTLER (12), Micheal MCKENNA (1), Jem CHALK (1), Layla LAVALLEE (1), Elizabeth HADLEY (1), Lucy CURETON (1), Magdalena BENYSEK (1), Monique ANDERSSON (13), Maria COATES (1), Sarah BARRETT (1), Clare BATEMAN (1), Jennifer DAVIES (1), Ivy RAYMUNDO-WOOD (1), Andrew USTIANOWSKI (14), Andrew CARSON-STEVENS (5), Ly-Mee YU (1), Paul LITTLE (8) - (1)University of Oxford, Royaume-Uni, (2)Institute of Immunity and Transplantation, University College London, Royaume-Uni, (3)Infection Inflammation and Immunology, UCL Great Ormond Street Institute of Child Health, Royaume-Uni, (4)University of Liverpool, Royaume-Uni, (5)University of Cardiff, Royaume-Uni, (6)University of Nottingham School of Medicine, Royaume-Uni, (7)Berry Consultants, Royaume-Uni, (8)University of Southampton, Royaume-Uni, (9)Windrush Medical Practice, Royaume-Uni, (10)University of Exeter, Royaume-Uni, (11)University of Glasgow, Royaume-Uni, (12)Queen’s University Belfast, Royaume-Uni, (13)Oxford University Hospitals NHS Foundation Trust, Royaume-Uni, (14)North Manchester General Hospital, Royaume-Uni | |
| 2-H Oral Session | 1146 | Outcomes of invasive fungal infections (IFI) due to Lomentospora prolificans infections treated with olorofim | Monica SLAVIN (1), Johan MAERTENS (2), Sharon CHEN (3), Christopher HEATH (4), Martin HOENIGL (5), Orla MORRISSEY (6), Hong NGUYEN (7), David PATERSON (8), George THOMPSON (9), Stephen WALSH (10), Daniela ZINZI (11), Lesley FITTON (11), Harvey EMMA (11), John REX (12) - (1)Peter Macullum Cancer Centre, Australie, (2)UK Leuven, Belgique, (3)Westmead Hospital, Australie, (4)Royal Perth Hospital and Fiona Stanley Hospital, Australie, (5)Medical University, Autriche, (6)The Alfred Hospital, Australie, (7)Pittsburg University, États-Unis, (8)Royal Brisbane and Womens Hospital, Australie, (9)UC Davis, États-Unis, (10)Brigham and Womens Hospital, États-Unis, (11)F2G Ltd, Royaume-Uni, (12)F2G Inc, États-Unis | |
| 2-H Oral Session | 170 | Side effects and factors influencing non-adherence to mass drug administration for malaria control in the context of a cluster randomised clinical trial (MATAMAL) on the Bijagós Archipelago, Guinea-Bissau | Maeve BARLOW (1), Harry HUTCHINS (1), Claire COLLIN (1), Eunice TEIXEIRA E SILVA (2), Beatriz SANCHEZ (1), Hamadou BOIRO (3), Amabelia RODRIGUES (4), Anna LAST (1) - (1)Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Royaume-Uni, (2)Ministry of Public Health, Guinée-Bissau, (3)Institute of Studies and Research, Guinée-Bissau, (4)Director of Research, Bandim Health Project, Guinée-Bissau | |
Top-rated posters
| Category | Poster number | Title | Co-Authors List |
|---|---|---|---|
Poster session 15.04 | |||
| Cat. 3 | P0052 | Geographical differences in strain diversity and antimicrobial resistance of S. epidermidis isolated from prosthetic joint infections in Sweden and France | Sofie EDSLEV (1), Frederic LAURENT (2), Emeli MÅNSSON (3), Camille KOLENDA (2), Bo SÖDERQUIST (4), Marc STEGGER (1, 4) - (1)Statens Serum Institut, Danemark, (2)French National Reference Center for Staphylococci, France, (3)Västmanland Hospital Västerås, Suède, (4)Örebro University, Suède |
| P0086 | In vitro activity of aztreonam-avibactam and comparator agents against Enterobacterales isolates collected from patients in intensive care units compared to other wards, ATLAS Global Surveillance Program, 2017-2021 | Mark ESTABROOK (1), Francis ARHIN (2), Daniel SAHM (1) - (1)IHMA, États-Unis, (2)Pfizer, IInc., Canada | |
| P0152 | The emergence of multidrug-resistant Klebsiella pneumoniae clones producing OXA-232, CTX-M-15, and RmtF in Indian hospitals | Shincy M R, Rose STEFFIMOL, Vandana GOVINDAN, Ravikumar K L - (1)Central Research Laboratory, Inde | |
| P0154 | In vitro activity of sulbactam-durlobactam (SUL-DUR) against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in US hospitals | Alina IOVLEVA (1), Christi MCELHENY (1), Erin FOWLER (1), Carol HILL (2), Keri BAUM (2), Vance FOWLER (2), Kerryl GREENWOOD-QUAINTANCE (3), Robin PATEL (3), Robert BONOMO (4), David VAN DUIN (5), Yohei DOI (1) - (1)University of Pittsburgh, États-Unis, (2)Duke Clinical Research Institute, États-Unis, (3)Mayo Clinic, États-Unis, (4)Case VA CARES and Louis Stokes VA Medical Center, États-Unis, (5)University of North Carolina, États-Unis | |
| P0205 | Genomic epidemiology of Neisseria gonorrhoeae and emergence of a strain harbouring TEM-type ESBL in Stockholm, Sweden | Nora VESTBERG, Karin HAIJ BHATTARAI, Hong FANG - (1)Department of Clinical Microbiology, Karolinska University Hospital, Suède | |
| P0306 | Cefiderocol in vitro activity against molecularly characterized Acinetobacter baumannii-calcoaceticus complex and Pseudomonas aeruginosa clinical isolates causing infection in Europe and adjacent regions (2020-2021) | Rodrigo MENDES, John KIMBROUGH, Dee SHORTRIDGE, Helio SADER, Mariana CASTANHEIRA - (1)JMI Laboratories, États-Unis | |
| P0576 | In vitro activity of cefepime-zidebactam and cefepime-taniborbactam against aztreonam-avibactam resistant NDM-like-producing Escherichia coli clinical isolates | Christophe LE TERRIER (1, 2), Patrice NORDMANN (1, 3, 4), Mustafa SADEK (1, 5), Laurent POIREL (1, 3) - (1)Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Suisse, (2)Division of Intensive care unit, University hospitals of Geneva, Suisse, (3)Swiss National Reference Center for Emerging Antibiotic Resistance, Suisse, (4)University of Lausanne and University hospital Center, Suisse, (5)Department of Food Hygiene and Control, Faculty of Veterinary Medicine, South Valley University, Égypte | |
| P0587 | Introducing the European bloodstream infections registry (EBSIR): an international database to facilitate data science in health and disease | Matthijs BERENDS (1, 2), Axel HAMPRECHT (3, 4), Adrian EGLI (5), Lukas SCHAFFARCZYK (3), Cansu CIMEN (1, 4), Andreas VOSS (1) - (1)University of Groningen, Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Pays-Bas, (2)Certe Medical Diagnostics & Advice Foundation, Department of Medical Epidemiology, Pays-Bas, (3)Institute for Medical Microbiology and Virology, University of Oldenburg, Allemagne, (4)University Medical Center Oldenburg, Allemagne, (5)University of Zurich, Institute of Medical Microbiology, Suisse | |
| P0607 | Antibiotic resistance gene burden and diversity vary in the general population according to demographics, diet, health, and geography | Katariina PÄRNÄNEN (1), Matti RUUSKANEN (1, 2), Pyry KANTANEN (1), Guillaume MÉRIC (3), Michael INOUYE (4, 5), Rob KNIGHT (6), Aki HAVULINNA (2), Veikko SALOMAA (2), Teemu NIIRANEN (1), Leo LAHTI (1) - (1)University of Turku, Finlande, (2)THL, Finlande, (3)Cambridge-Baker Systems Genomics Initiative Baker Heart & Diabetes Institute, Australie, (4)Dept Public Health & Primary Care, University of Cambridge, Royaume-Uni, (5)Cambridge Baker Systems Genomics Initiative, Royaume-Uni, (6)University of California, San Diego, États-Unis | |
| P0660 | A comparative assessment of the burden of antimicrobial resistance among different WHO regions: implications for policy, practice and future research | Tomislav MESTROVIC (1, 2) - (1)University North, Croatie, (2)University of Washington School of Medicine, États-Unis | |
| Cat. 8 | P0688 | Tailored therapy with dalbavancin as long-term suppressive treatment in patients with vascular graft infections | Tosca SEMENZIN (1), Paola DELLA SIEGA (1), Federico PEA (2), Pier Giorgio COJUTTI (2), Marco COTRUFO (1), Fabiana DELLAI (1), Carlo TASCINI (1) - (1)Infectious diseases Clinic, Azienda Sanitaria Universitaria Friuli Centrale, Italie, (2)Department of Pharmacology, Università degli studi di Bologna, Italie |
| P0748 | Cost analysis of health care-acquired infections in a teaching hospital: a comparison of methods | Guglielmo GIRALDI (1), Montesano MARZIETTA (2), Francesca Maria FORESTIERO (1), Maria Assunta DONATO (1), Paolo LOMBARDO (1), Francesco STELLA (2), Giovanni Battista ORSI (1) - (1)Department of Public Health and Infectious Disease, Sapienza University of Rome, Italie, (2)Teaching Hospital Sant’Andrea, Sapienza University of Rome, Italie | |
| P0754 | Successful elimination of clonally spreading Stenotrophomonas maltophilia causing bloodstream infections in critically ill COVID-19 patients | Renáta HARGITAI, Réka MESZÉNA, Tamás KISS, Beáta POLGÁR, Krisztina KOVACS, Hajnalka FENYVESI, Péter URBÁN, Attila GYENESEI, Erika RAUTH, Tibor PÁL, Ágnes SONNEVEND - (1)University of Pécs, Hongrie | |
| P0797 | Aerosolization of Mycobacterium chelonae from heater-cooler-devices: a continuing risk of exposure during cardiac surgery | Sabine KUSTER (1), Silvio RAGOZZINO (1), Matthias VON ROTZ (1), Richard KUEHL (1), Gioele CAPOFERRI (1), Pascal URWYLER (1), Thomas DOEBELE (2), Friedrich ECKSTEIN (2), Daniel GOLDENBERGER (3), Pascal SCHLAEPFER (4), Sarah TSCHUDIN-SUTTER (1) - (1)Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Suisse, (2)Division of Cardiac Surgery, University Hospital Basel, Suisse, (3)Division of Clinical Bacteriology / Mycology, University Hospital Basel, Suisse, (4)Laboratory Medicine, University Hospital Basel, Suisse | |
| Cat. 9 | P0948 | Evolution of virulence, fitness, and carbapenem resistance transmission in ST23 hypervirulent Klebsiella pneumoniae with the capsular polysaccharide synthesis gene wcaJ inserted via insertion sequence elements | Wang SHUYI, Ding QI, Zhang YAWEI, Zhang ANRU, Wang QI, Wang RUOBING, Wang XIAOJUAN, Jin LONGYANG, Ma SHUAI, Wang HUI - (1)Department of Clinical Laboratory, Peking University People's Hospital, Chine |
| P0985 | Cell death of primary microglia by Streptococcus pneumoniae largely depends on hydrogen peroxide, not on pneumolysin | Franziska JENNERT (1), Désirée SCHAAF (1), Roland NAU (2, 3), Thomas KOHLER (4), Sven HAMMERSCHMIDT (4), Darius HÄUSLER (2, 5), Peter VALENTIN-WEIGAND (1), Jana SEELE (2, 3) - (1)University of Veterinary Medicine Hannover, Institute for Microbiology, Center for Infection Medicine, Allemagne, (2)University Medical Center Göttingen, Department of Neuropathology, Allemagne, (3)Evangelisches Krankenhaus Göttingen-Weende, Department of Geriatrics, Allemagne, (4)Greifswald University, Department of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Allemagne, (5)Fraunhofer-Institute for Translational Medicine and Pharmacology ITMP, Allemagne | |
| P1030 | StM171, a Stenotrophomonas maltophilia bacteriophage that represents a new genus and affects antibiotic activity | Ghadeer JDEED (1), Vera MOROZOVA (2), Yuliya KOZLOVA (2), Artem TIKUNOV (2), Nina TIKUNOVA (2) - (1)Novosibirsk State University, Russie, fédération de, (2)Institute of Chemical Biology and Fundamental Medicine, Russie, fédération de | |
Poster session 16.04 | |||
| Cat. 2 | P1067 | Protective and risk factors for Buruli ulcer in an endemic region: a comprehensive case control study, Victoria Australia | Bridgette MCNAMARA (1, 2), Kim BLASDELL (3), Daniel O'BRIEN (1), Arvind YERAMILLI (1), Ina SMITH (3), Simone CLAYTON (3), Michael DUNN (3), Eelaine TAY (4), Katherine GIBNEY (5), Nilakshi WAIDYATILLAKE (2, 6), Akhtar HUSSAIN (1), Michael MULEME (1), Tim STINEAR (7), Eugene ATHAN (1, 6) - (1)Barwon South West Public Health Unit, Barwon Health, Australie, (2)Centre for Epidemiology and Biostatistics, University of Melbourne, Australie, (3)Health and Biosecurity, Commonwealth Scientific and Industrial Research Organisation, Australie, (4)Department of Health, Victoria, Australie, (5)Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Australie, (6)School of Medicine, Deakin University, Australie, (7)Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity University of Melbourne, Australie |
| P1390 | Interim analysis of a longitudinal study on sexual health in females | Frederike WALDECK, Nadja KÄDING, Mariia LUPATSII, Lena DÖLING, Simon GRASPEUNTNER, Jan RUPP - (1)Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Campus Luebeck, Allemagne | |
| P1423 | Ceftazidime/avibactam for CRKP ventriculitis after neurosurgery: pharmacokinetic and blood-brain barrier penetration | Nanyang LI, Jing ZHANG, Jin HU, Lei YANG, Xu ZHU, Jufang WU, Xiangru YE, Meihua WANG, Haijun YAO, Biwu WU, Hailan WU, Wanzhen LI, Yuancheng CHEN, Jinjie HE, Xingchen BIAN, Size LI, Yinru CHEN, Yun ZHOU, Ying MAO - (1)Huashan Hospital, Fudan University, Chine | |
| P1425 | Epidemiology of Acinetobacter baumannii among adult patients across United States hospitals | Thomas LODISE (1), Sean NGUYEN (2), Jennifer COPELAND (2), Caroline MARGIOTTA (3), Bin CAI (2) - (1)Albany College of Pharmacy and Health Sciences, États-Unis, (2)Shionogi Inc., États-Unis, (3)Genesis Research LLC, États-Unis | |
| Cat. 4 | P1531 | Performance evaluation of the Mini-Lab, an all-in-one clinical bacteriology laboratory adapted to low-resource settings, in a district hospital in Central African Republic | Céline LANGENDORF (1), Alessandra NATALE (2), Jean-Baptiste RONAT (2), Thomas VIDAL (2), Bernard BAILLET (3), Céline FRANQUESA (2), Kerry DIERBERG (2), Rupa KANAPATHIPILLAI (2), Justine MICHEL (2), Jan JACOBS (3), Olivier VANDENBERG (4) - (1)Epicentre, France, (2)Médecins sans Frontières, France, (3)Institute of Tropical Medicine, Belgique, (4)Université Libre de Brussels, Belgique |
P1660 | Xpert MTB/RIF or Ultra for the diagnosis of tuberculous meningitis in South Africa | Marianne BLACK (1, 2), Bianca BOOYSEN (1), Amadi IHUNWO (1), Andre MOCHAN (1), Nepo KETSO (1), Aluwani NEDZINWANI (1), Dominic BOULLE (1), Mandisa MBANJWA (1), Sabeehah CHAND (1), Uzayr EBRAHIM (1) - (1)University of the Witwatersrand, Afrique du Sud, (2)National Health Laboratory Service, Afrique du Sud | |
| P1765 | Streptococcus pneumoniae genotypes 23B0 and 23B1 show distinct genomic characteristics and evidence of parallel non-convergent evolution | Juan Pablo RODRIGUEZ-RUIZ (1), Lara DIERCKX (1), Liesbet VAN HEIRSTRAETEN (1), Christine LAMMENS (1), Esra EKINCI (2), Laura WILLEN (2), Lize CUYPERS (3), Heidi THEETEN (2), Stefanie DESMET (3), Surbhi MALHOTRA-KUMAR (1) - (1)Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Belgique, (2)Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Belgique, (3)National Reference Centre for Invasive Pneumococci, University Hospitals Leuven, Belgique | |
| P1768 | Genomic characterisation of Enterococcus lactis misclassified as Enterococcus faecium from bloodstream infections in Australia, 2021 | Shakeel MOWLABOCCUS (1, 2, 3, 4), Princy SHOBY (1), Denise DALEY (2, 4), Geoffrey COOMBS (1, 2, 4) - (1)Antimicrobial Resistance and Infectious Diseases Research Laboratory, Murdoch University, Australie, (2)Department of Microbiology, PathWest Laboratory Medicine – WA, Fiona Stanley Hospital, Australie, (3)School of Biomedical Sciences, University of Western Australia, Australie, (4)Australian Group on Antimicrobial Resistance, Fiona Stanley Hospital, Australie | |
| P1789 | Evaluation of Fourier transform infrared spectroscopy for typing carbapenemase-producing E. cloacae | Violeta GARCÍA-CASAS (1), Lucía PÉREZ-RODRÍGUEZ (1), Esther RECACHA (2), Inmaculada LÓPEZ-HERNÁNDEZ (2), Natalia CHUECA (1) - (1)San Cecilio Hospital, Espagne, (2)Virgen Macarena Hospital, Espagne | |
| P1811 | Utility of whole genome sequencing to characterise toxigenic Corynebacterium diphtheriae isolates among asylum seekers in England | Joshua D'AETH (1), Shennae O'BOYLE (2), Colin BROWN (3), Seyi ELETU (1), Katie L. HOPKINS (3), Danièle MEUNIER (3), Mariyam MIRFENDERESKY (3), Rebecca CORDERY (2), David LITT (1), Gayatri AMIRTHALINGAM (2), Norman K. FRY (1, 2) - (1)Vaccine Preventable Bacteria Section, Respiratory and Vaccine Preventable Bacteria Reference Unit, Specialised Microbiology and Laboratories Directorate, UK Health Security Agency, Royaume-Uni, (2)Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, Royaume-Uni, (3)Healthcare Associated Infections, Fungal, Antimicrobial Resistance, Antimicrobial Usage and Sepsis Division, UK Health Security Agency, Royaume-Uni | |
| P1853 | Blood2Bac: a rapid, direct-from-blood diagnostic assay for bacteremia using ultrahigh bacterial enrichment and whole genome sequencing | Douglas KWON (1, 2), Manoj NAIR (1), Matthew TURNER (1), Defne SURUJON (1), Ian HERRIOTT (1), Emily MACLEOD (1), Rachel MARTIN (1), Cristina RUSHTON (1), Alfred WONG (1), Kaitlin WOODRUFF (1), Claire ZIMMERMAN (1), Linnea SAHLBERG (1), Cabell MADDUX (1), Mohamad SATER (1), Miriam HUNTLEY (1) - (1)Day Zero Diagnostics, États-Unis, (2)Ragon Institute of MGH, MIT and Harvard, États-Unis | |
| P1862 | Predicting ESBL with over 99% certainty, fast and for free: do we still require expensive and slow laboratory confirmation tests? | Matthijs BERENDS (1, 2), Dennis SOUVEREIN (3), Joppe VAN DUIJN (4), Rogier SCHADE (5), Sjoerd EUSER (3), Andreas VOSS (6) - (1)Certe Medical Diagnostics & Advice Foundation, Department of Medical Epidemiology, Pays-Bas, (2)University of Groningen, Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, (3)Regional Public Health Laboratory Kennemerland, Pays-Bas, (4)Certe Medical Diagnostics & Advice Foundation, Department of Medical Microbiology, Pays-Bas, (5)Amsterdam University Medical Centre, Department of Medical Microbiology and Infection Control, Pays-Bas, (6)University of Groningen, Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Pays-Bas | |
| Cat. 6 | P1914 | One Health approach to resistance of Aspergillus fumigatus to azoles in Hauts-de-France | Sophie HARTUIS (1, 2), Taieb CHOUAKI (3), Estelle ROBERT (4), Carine PICOT (4), Sophie ROUSSELLE (3), Jean Marc FOSSIER (3), Boualem SENDID (5, 6), Rose-Anne LAVERGNE (1, 2), Patrice LE PAPE (1, 2) - (1)Department of Parasitology and Medical Mycology, UR1155 IICiMed, Nantes University,, France, (2)Laboratory of Parasitology and Medical Mycology, Institute of Biology, Nantes University Hospital , France, (3)Laboratory of Parasitology and Medical Mycology, Amiens University Hospital, France, (4)Laboratory of Parasitology and Medical Mycology, Institute of Biology, Nantes University Hospital, France, (5)Laboratory of Parasitology and Medical Mycology, Lille University Hospital,, France, (6)InsermU1285, CNRS UMR8576 Lille University , France |
Poster session 17.04 | |||
| Cat. 1 | P2817 | Acute hepatitis of unknown origin in children: analysis of seventeen consecutive cases between April and November 2022 admitted to the Bambino Gesù Children's Hospital in Rome | Velia Chiara DI MAIO (1), Leonarda GENTILE (1), Luna COLAGROSSI (1), Luana COLTELLA (1), Stefania RANNO (1), Giulia LINARDOS (1), Daniela LICCARDO (2), Maria Sole BASSO (2), Simona LANDI (1), Marta CIOFI DEGLI ATTI (3), Lara RICOTTA (4), Giuseppe MAGGIORE (2), Massimiliano RAPONI (4), Cristina RUSSO (1), Carlo Federico PERNO (1) - (1)Department of Laboratories, Unit of Diagnostic Microbiology and Immunology and Multimodal Medicine Area, Bambino Gesù Children's Hospital IRCCS, Italie, (2)Hepatology, Gastroenterology, Nutrition, Digestive Endoscopy and Liver Transplantation Unit, Bambino Gesù Children's Hospital IRCCS, Italie, (3)Clinical Pathways and Epidemiology Unit, Bambino Gesù Children's Hospital IRCCS, Italie, (4)Medical Direction, Bambino Gesù Children's Hospital, IRCCS, Italie |
| P2864 | Respiratory syncytial virus: a systematic review and meta-analysis of tomographic findings (2000 – 2022) | Matteo RICCÒ (1), Silvia CORRADO (2), Sara PALMIERI (3) - (1)Dipartimento di Sanità Pubblica, AUSL-IRCCS di Reggio Emilia, Italie, (2)Department of Medicine DAME—Division of Pediatrics, University of Udine, Italie, (3)ASST Spedali civili di Brescia, Italie | |
| P2891 | An improved ex vivo rat model of tick-borne encephalitis | Simone LEONI, Denis GRANDGIRARD, Stephen L. LEIB - (1)Institute for Infectious Diseases, University of Bern, Suisse | |
| Cat. 5 | P2099 | WCK 4282 (cefepime/tazobactam, FEP/TAZ): determination of tazobactam pharmacodynamic targets (PDTs) in presence of cefepime employing piperacillin/tazobactam-resistant ESBL or OXA-48-like-expressing Enterobacterales | Anouk MULLER (1, 2, 3), Sanne VAN DEN BERG (2, 3), Kushal UMARKAR (4), Pavan TAYDE (4), Melroy TELLIS (4), Ashwani KUMAR (4), Rajesh CHAVAN (4), Vineet ZOPE (4), Swapna TAKALKAR (4), Hariharan PERIASAMY (4) - (1)Haaglanden Medisch Centrum, Pays-Bas, (2)Erasmus MC, University Medical Center, Pays-Bas, (3)Center for Antimicrobial Optimized Treatment Rotterdam (CATOR), Pays-Bas, (4)Wockhardt Research Center, Inde |
| P2153 | Therapeutic bacteriocins targeting drug-resistant Enterobacteriaceae | D. N SRIVIDYA - (1)GangaGen Biotechnologies Pvt. Ltd, Inde | |
| P2192 | Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multi-centre randomised clinical trial | Tim EWOLDT (1, 2, 3), Alan ABDULLA (1, 3), Wim RIETDIJK (1), Anouk MULLER (4, 5, 3), Brenda DE WINTER (1, 3), Nicole HUNFELD (1, 2), Ilse PURMER (6), Peter VAN VLIET (7), Evert-Jan WILS (8), Jasper HARINGMAN (9), Annelies DRAISMA (10), Tom RIJPSTRA (11), Attila KARAKUS (12), Diederik GOMMERS (2), Endeman HENRIK (2), Birgit KOCH (1, 3) - (1)Hospital Pharmacy, Erasmus University Medical Center, Pays-Bas, (2)Department of Intensive Care Medicine, Erasmus University Medical Center, Pays-Bas, (3)Rotterdam Clinical Pharmacometrics Group, Pays-Bas, (4)Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Pays-Bas, (5)Department of Medical Microbiology, Haaglanden Medical Center, Pays-Bas, (6)Department of Intensive Care Medicine, Haga hospital, Pays-Bas, (7)Department of Intensive Care Medicine, Haaglanden Medical Center, Pays-Bas, (8)Department of Intensive Care Medicine, Franciscus Gasthuis en Vlietland, Pays-Bas, (9)Department of Intensive Care Medicine, Isala Hospital, Pays-Bas, (10)Department of Intensive Care Medicine, Groene Hart Ziekenhuis, Pays-Bas, (11)Department of Intensive Care Medicine, Amphia Hospital, Pays-Bas, (12)Department of Intensive Care Medicine, Diakonessenhuis, Pays-Bas | |
| Cat. 7 | P3134 | Association between extreme climate events and waterborne and environmental infectious diseases in Belgium from 2011 to 2021 | Zineb FACHQOUL (1), Nicolas YIN (2), Dieter VAN CAUTEREN (3), Sigi VAN DEN WIJNGAERT (2), Delphine MARTINY (2), Marie HALLIN (1), Olivier VANDENBERG (1, 4) - (1)Centre for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB), Belgique, (2)Department of Microbiology, LHUB-ULB, Université Libre de Bruxelles (ULB), Belgique, (3)Scientific Directorate of Epidemiology and Public Health, Sciensano, Belgique, (4)Innovation and Business Development Unit, LHUB-ULB, Université Libre de Bruxelles (ULB), Belgique |
| Cat. 10 | P2950 | Cytomegalovirus resistance to letermovir was uncommon among participants enrolled in the phase 3 trial of letermovir prophylaxis in kidney transplant recipients | Julie STRIZKI, Valerie L. TEAL, Christopher L. GILBERT, Weiwen WANG, Nicole STAUFFER, Barbara HABER - (1)Merck & Co., Inc.,, États-Unis |
| P2983 | Stalk antibodies after seasonal influenza vaccination | Laura SÁNCHEZ-DE PRADA (1, 2), Iván SANZ-MUÑOZ (2), Raúl ORTIZ DE LEJARAZU (2), José María EIROS (2, 1), Adolfo GARCÍA-SASTRE (3, 4, 5), Teresa AYDILLO (3, 4) - (1)Department of Microbiology, Hospital Clínico Universitario de Valladolid, Espagne, (2)National Influenza Centre of Valladolid, Espagne, (3)Department of Microbiology, Icahn School of Medicine at Mount Sinai, États-Unis, (4)Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, États-Unis, (5)Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, États-Unis | |
| P3021 | A phase 1/2a study of the safety, reactogenicity, and immunogenicity of 10-valent ExPEC10V bioconjugate vaccine (VAC52416) in adults with a history of urinary tract infection | Carlos FIERRO (1), Sarnecki MICHAL (2), Spiessens BART (3), Go OSCAR (4), Day TRACEY (5), Davies TODD (4), Van Den Dobbelsteen GERMIE (6), Poolman JAN (6), Abbanat DARREN (7), Haazen WOUTER (3) - (1)Johnson County Clin-Trials, Îles mineures éloignées des États-Unis, (2)Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Vaccines, Suisse, (3)Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica, Belgique, (4)anssen Research & Development, États-Unis, (5)Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V. - Leiden (Netherlands), Pays-Bas, (6)Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V., Pays-Bas, (7)Janssen Research & Development, Pays-Bas | |
| Cat. 12 | P2414 | Thymic involution and attenuated T cell maturation induced by SARS-CoV-2 infection | Zaigham Abbas RIZVI, Amit AWASTHI - (1)THSTI, Inde |
| P2476 | AMR & COVID-19: preliminary findings from the WHO Global Clinical Platform for COVID-19 | Daniele DONA', Silva RONALDO, Edith MILANZI, Soe Soe THWIN, Firdavs KURBONOV, Janet Victoria DIAZ, Silvia BERTAGNOLIO - (1)World Health Organization, Suisse | |
| P2491 | Infectious complications and long-term follow up results of COVID-19 in solid organ transplant recipients | Imran HASANOĞLU (1), Alpay ARI (2), Güle CINAR (3), Gokalp OKUT (2), Tugba YANIK YALCIN (4), Ayse Ozlem METE (5), Kemal Osman MEMIKOGLU (3), Adalet ALTUNSOY (6), Bengu TATAR (7), Tansu YAMAZHAN (8), Derya SEYMAN (9), Kemalettin OZDEN (10), Ebru ORUC (11), Oya EREN KUTSOYLU (12), Kenan HIZEL (13), Yesim UYGUN KIZMAZ (14), Selcan ARSLAN OZEL (15), Ozge OZGEN TOP (16), Sevil ALKAN (17), Nilgun ALTIN (18), Mehmet KARABAY (19), Erhan TATAR (7), Onur Elvan KIRIMKER (3), Emre KARAKAYA (4), Aziz BULUT (5), Erkan OLCUCUOGLU (6), Dilara TURAN GOKCE (6), Cem TUGMEN (7), Buse KENANOGLU (8), Arif ASLANER (9), Gurkan OZTURK (20), Suleyman CETINKUNAR (11), Tufan EGELI (12), Ebru Sevinc OK (13), Ayse Nigar HALIS (14), Bekir VOYVODA (21), Ozant HELVACI (16), Hasan Anil KURT (17), Hatice SAHIN (18), Hande ARSLAN (4) - (1)Ankara Yildirim Beyazit University Ankara City Hospital, Turquie, (2)S.B.U Izmir Bozyaka Education and Research Hospital, Turquie, (3)Ankara University Faculty of Medicine, Turquie, (4)Baskent University Faculty of Medicine, Turquie, (5)Gaziantep University Faculty of Medicine, Turquie, (6)S.B.U. Ankara City Hospital, Turquie, (7)S.B.U. Izmir Tepecik Education and Research Hospital, Turquie, (8)Ege University Faculty of Medicine, Turquie, (9)S.B.U. Antalya Education and Research Hospital, Turquie, (10)University Faculty of Medicine, Turquie, (11)S.B.U. Adana City Hospital, Turquie, (12)Dokuz Eylul University Faculty of Medicine, Turquie, (13)Kent Hospital, Turquie, (14)Kosuyolu Yuksek Ihtisas Education and Research Hospital, Turquie, (15)S.B.U. Derince Education and Research Hospital, Turquie, (16)Gazi University Faculty of Medicine, Turquie, (17)Canakkale 18 Mart University Faculty of Medicine, Turquie, (18)S.B.U. Etlik City Hospital, Turquie, (19)Medicana Bahcelievler Hospital, Turquie, (20)Ataturk University Faculty of Medicine, Turquie, (21)Atasehir Medicana Hospital, Turquie | |
| P2618 | Outcomes following molnupiravir treatment during the COVID-19 Omicron surge in Israel | Clara WEIL (1), Tobias BERGROTH (2), Anna EISENBERG (3), Yohance WHITESIDE (4), Yoseph CARACO (5), Lilac TENE (1), Gabriel CHODICK (1) - (1)MaccabiTech, Maccabi Healthcare Services, Israël, (2)Center for Observational and Real-world Evidence (CORE), MSD, Suède, (3)MSD, Israël, (4)Center for Observational and Real-world Evidence (CORE), Merck & Co., Inc, États-Unis, (5)Hadassah-Hebrew University Medical Center, Israël | |
| P2620 | Pharmacokinetics, safety and tolerability of GS-5245 in healthy participants | Olena ANOSHCHENKO, Mazin ABDELGHANY, Robert H HYLAND, Santosh DAVIES, Christine MKAYA, Gong SHEN, Deqing XIAO, Helen WINTER, Joe LLEWELLYN, Rita HUMENIUK - (1)Gilead Sciences, États-Unis | |
| P2635 | Efficacy and safety of remdesivir in people with moderately and severely reduced kidney function hospitalised for COVID-19: the REDPINE study | Jose Ramon SANTOS FERNANDEZ (1), Jason D GOLDMAN (2), Katherine R TUTTLE (3), J. Pedro TEIXEIRA (4), Yiannis KOULLIAS (5), Joe LLEWELLYN (5), Yang ZHAO (5), Hailin HUANG (5), Robert H HYLAND (5), Anu OSINUSI (5), Rita HUMENIUK (5), Henry HULTER (6), Robert L GOTTLIEB (7), Dahlene N FUSCO (8), Rita BIRNE (9), Fernando F STANCAMPIANO (10), Claudia R LIBERTIN (10), Mark MCPHAIL (11), Meghan SISE (12) - (1)Hospital Universitari Germans Trias i Pujol, Espagne, (2)Swedish Medical Center, États-Unis, (3)Providence Inland Northwest Health, États-Unis, (4)University of New Mexico Hospital, États-Unis, (5)Gilead Sciences, Inc., États-Unis, (6)University of California, États-Unis, (7)Baylor University Medical Center and Baylor Scott & White Research Institute, États-Unis, (8)Tulane University, États-Unis, (9)Centro Hospitalar de Lisboa Ocidental, EPE, États-Unis, (10)Mayo Clinic College of Medicine and Science, États-Unis, (11)King’s College Hospital, Royaume-Uni, (12)Massachusetts General Hospital, États-Unis | |
Poster session 18.04 | |||
| Cat. 11 | P3483 | The use of comics as a tool to educate junior high school students in the Ashanti Region of Ghana about antimicrobial resistance and its impact on their knowledge | Kwame Ohene BUABENG, Obed Kwabena Offe AMPONSAH, Marie Millicent BAFFOE-BONNIE, Marie Millicent BAFFOE-BONNIE - (1)Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Ghana |
| P3492 | Exploring the impact of co-morbidities on empiric treatment of urinary tract infections and antimicrobial resistance in a large dataset | William BOLTON (1, 2, 3), Pantelis GEORGIOU (1, 4), Alison HOLMES (1, 5, 6), Timothy RAWSON (1, 5) - (1)Centre for Antimicrobial Optimisation, Imperial College London, Royaume-Uni, (2)AI4Health Centre for Doctoral Training, Imperial College London, Royaume-Uni, (3)Department of Computing, Imperial College London, Royaume-Uni, (4)Centre for Bio-inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, Royaume-Uni, (5)National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Royaume-Uni, (6)Department of Infectious Diseases, Imperial College London, Royaume-Uni | |
| Cat. 13 | P3243 | Disseminated heteroresistant Mycobacterium kansasii infection mimicking nasopharyngeal cancer in a woman with positive anti-interferon-gamma autoantibodies | Chih-Han JUAN (1, 2), Chi-Ping TAN (3), Yi-Tsung LIN (1, 2), Ting-Shu WU (4, 5) - (1)Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taïwan, République de Chine, (2)Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taïwan, République de Chine, (3)Department of Medicine, Taipei Veterans General Hospital, Taïwan, République de Chine, (4)Infectious Diseases, Internal Medicine, Chang Gung Memorial Hospital, Lin-Kou Medical Center, Taïwan, République de Chine, (5)Chang Gung University College of Medicine, Taïwan, République de Chine |
| P3347 | Successful repeat liver transplantation during treatment for invasive pulmonary aspergillosis and pulmonary nocardiosis: a case report | Sarah COLE, Siong HUI - (1)Sir Charles Gairdner Hospital, Australie | |
